Effect of in Vitro Blocking the Common Beta Chain on the Function of Blood, Bone Marrow and Sputum Cells Collected From Asthmatic Donors.
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2017
Price : $35 *
At a glance
- Drugs CSL 311 (Primary)
- Indications Allergic asthma
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 22 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jan 2013 New trial record